Treatment of COVID-19 in pregnant women: A systematic review and meta-analysis

•Pregnancy-specific interventions, such as the mode of delivery or the type of anaesthesia appears to be related with severity of disease, but not with perinatal outcomes.•There is an association with caesarean section and the likelihood of being admitted to ICU or due to adverse effects of COVID-19...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of obstetrics & gynecology and reproductive biology 2021-12, Vol.267, p.120-128
Hauptverfasser: Giesbers, Steven, Goh, Edwina, Kew, Tania, Allotey, John, Brizuela, Vanessa, Kara, Edna, Kunst, Heinke, Bonet, Mercedes, Thangaratinam, Shakila, Chatterjee, Shaunak, Gae, Andrea, Stallings, Elena, Yap, Magnus, Sheikh, Jameela, Lawson, Heidi, Coomar, Dyuti, Dixit, Anushka, Zhou, Dengyi, Balaji, Rishab, Littmoden, Megan, King, Yasmin, Debenham, Luke, Clavé Llavall, Anna, Ansari, Kehkashan, Sandhu, Gurimaan, Banjoko, Adeolu, Fraser, Helen, Rajah, Tanisha, Ramkumar, Anoushka, Khashaba, Alya, Attarde, Shruit, Walker, Kate, Thornton, Jim, van Wely, Madelon, van Leeuwen, Elizabeth, Kostova, Elena, Khalil, Asma, Tiberi, Simon, Broutet, Nathalie, Rahn Kim, Caron, Thorson, Anna, Oladapo, Olufemi T., Zamora, Javier, Mofenson, Lynne
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Pregnancy-specific interventions, such as the mode of delivery or the type of anaesthesia appears to be related with severity of disease, but not with perinatal outcomes.•There is an association with caesarean section and the likelihood of being admitted to ICU or due to adverse effects of COVID-19 pneumonia.•We encourage researchers to include pregnant women in their trials and when they do so, to report them separately. Clinical trials evaluating pharmacological and non-pharmacological treatment of COVID-19, either excluded pregnant women or included very few women. Unlike the numerous systematic reviews on prevalence, symptoms and adverse outcomes of COVID-19 in pregnancy, there are very few on the effects of treatment on maternal and neonatal outcomes in pregnancy. We undertook a systematic review of all published and unpublished studies on the effects of pharmacological and non-pharmacological interventions for COVID-19 on maternal and neonatal pregnancy outcomes. We performed a systematic literature search of the following databases: Medline, Embase, Cochrane database, WHO (World Health Organization) COVID-19 database, China National Knowledge Infrastructure (CNKI), and Wanfang databases from 1 December 2019 to 1 December 2020. Studies were only included if they involved pregnant or postnatal women who were exposed to pregnancy specific interventions like the mode of delivery and type of anaesthesia, pharmacological or non-pharmacological interventions. We first screened the titles and abstracts of studies and then assessed the full text of the selected studies in detail for eligibility. Data on study design, population, type of screening for COVID-19, country, hospital, country status (high or low and middle income), treatment given (mode of delivery, type of anaesthesia, type of pharmacological and non-pharmacological treatment was extracted. The pre-defined maternal outcomes we collected were mode of delivery (vaginal or by caesarean section), severe or critical COVID-19 (as defined by the authors), symptomatic COVID-19, maternal death, maternal hospital admission, ICU admission, mechanical ventilation, ECMO and maternal pneumonia. The pre-defined neonatal outcomes we extracted were preterm birth (
ISSN:0301-2115
1872-7654
DOI:10.1016/j.ejogrb.2021.10.007